Joerg Schreiber

Quadraspec, Inc. is a diagnostic company engaged in the development of in-vitro diagnostic products for the laboratory, clinical, research and life sciences markets. Their products are used in veterinary for canine heartworm, by biotechnology companies for assay development, biomarker identification, and patient screening during pre-clinical and clinical development and in clinical diagnostics. It developed a direct detection technology which eliminates the usage of secondary and labeled reagents. The company’s proprietary Spinning Disc Interferometry (SDI) Detection technology platform detects and quantifies more than 1,000 unique antigens, biomarkers, or other molecular species on a single array providing a reagent-free detection technology. Its dual channel detector, Inspira Reader features reagent-free detection and orthogonal detection method for quantification of molecular assays. The company was founded in 2004 and is headquartered in West Lafayette, Indiana.

Roche Diagnostics Corp. develops and manufactures diagnostic products. It offers anticoagulation management, blood gas and electrolytes, cholesterol and urinalysis products. The firm provides a broad portfolio of tools that help healthcare providers in the prevention, diagnosis and management of diseases like HPV, HIV, heart failure and diabetes, as well as other medical conditions, such as fertility and blood coagulation. Its products and services uses by researchers, physicians, patients, hospitals and laboratories worldwide. The company was founded in 1964 by Willard Eason and is headquartered in Indianapolis, IN.

Mydoc.com provides 24-hour online health care service and medical resources. The private company is based in Indianapolis, IN. Mydoc.com was acquired by US Health Services Corp. from Roche Holding AG on June 12, 2003 for $0.65 million.

AION Diagnostics, Inc. is a global research-based imaging and biotechnology company dedicated to the commercialization of medical imaging contrast and molecular imaging agents for early stage detection of critical diseases. The company secured strategic alliances with universities, research institutions and industry partners internationally. Its medical imaging systems evolve to include combination imaging techniques in a single scan, there is a new emerging demand for hybrid imaging agents. It provides the clinician with the ability to provide the contrast required for imaging an ultrasound, X-ray, CT, PET or MRI. AION has created a unique imaging platform with the ability to be visualized on key imaging modalities in a single formulation. It has advanced the platform to multi-modality applications in: marking agents, hybrid contrast agents and next-generation hybrid molecular imaging agents. The company was founded in 2004 and is headquartered in Subiaco, Australia.

Maradin Ltd. develops and manufactures micro electro-mechanical systems (MEMS) laser scanning mirrors and controllers for a wide range of applications, including pico-projectors, automotive heads up display (HUD), medical devices, industrial devices, and defense instruments. It offers the MAR1800, a MEMS two-dimensional (2D) vector scanning mirror module, comprises of two single axis vector scanners, attached together and MAR2100, a driver and control IC for Maradin’s MAR1100 dual-axis MEMS based scanning. The company was founded by Adi Baram, Elon Littwitz, and Matan Naftali in 2007 and is headquartered in Yokneam, Israel.